Steven R. Lentz

Internal Medicine

200 Hawkins Dr
Iowa City, IA 52242

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 113 publications

Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors.

Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors.

Journal: The New England journal of medicine

Published: April 29, 2026

Real-world analysis of extended half-life product posology in hemophilia A: results from a retrospective analysis of medical chart and claims data.

Real-world analysis of extended half-life product posology in hemophilia A: results from a retrospective analysis of medical chart and claims data.

Journal: Expert review of hematology

Published: June 18, 2025

Pyruvate kinase M2 promotes venous thrombosis by enhancing SNAP23-mediated platelet exocytosis and consequent NETosis.

Pyruvate kinase M2 promotes venous thrombosis by enhancing SNAP23-mediated platelet exocytosis and consequent NETosis.

Journal: Blood advances

Published: June 09, 2025

Platelet defects in patients and mice with Ehlers-Danlos syndrome.

Platelet defects in patients and mice with Ehlers-Danlos syndrome.

Journal: Blood

Published: May 09, 2025

Platelet defects in patients and mice with Ehlers-Danlos syndrome.

Platelet defects in patients and mice with Ehlers-Danlos syndrome.

Journal: Blood

Published: May 09, 2025

FRONTIER1 multiple ascending dose extension: a safety, tolerability, pharmacokinetics, and pharmacodynamics study of Mim8 in people with hemophilia A.

FRONTIER1 multiple ascending dose extension: a safety, tolerability, pharmacokinetics, and pharmacodynamics study of Mim8 in people with hemophilia A.

Journal: Research and practice in thrombosis and haemostasis

Published: April 17, 2025

Corrigendum to 'FRONTIER1: a partially randomized phase 2 study assessing the safety, pharmacokinetics, and pharmacodynamics of Mim8, a factor VIIIa mimetic': [Journal of Thrombosis and Haemostasis Volume 22, Issue 4, April 2024, Pages 990-1000].

Corrigendum to 'FRONTIER1: a partially randomized phase 2 study assessing the safety, pharmacokinetics, and pharmacodynamics of Mim8, a factor VIIIa mimetic': [Journal of Thrombosis and Haemostasis Volume 22, Issue 4, April 2024, Pages 990-1000].

Journal: Journal of thrombosis and haemostasis : JTH

Published: February 21, 2025

Elevated tissue factor pathway inhibitor delays thrombin generation in COVID-19 but is not associated with clinical outcomes.

Elevated tissue factor pathway inhibitor delays thrombin generation in COVID-19 but is not associated with clinical outcomes.

Journal: Blood vessels, thrombosis & hemostasis

Published: February 05, 2025

Anticoagulation Among Patients Hospitalized for COVID-19 : A Systematic Review and Prospective Meta-analysis.

Anticoagulation Among Patients Hospitalized for COVID-19 : A Systematic Review and Prospective Meta-analysis.

Journal: Annals of internal medicine

Published: December 23, 2024

New American Society of Hematology Thrombophilia Guidelines Could Provoke Surge in Laboratory Testing.

New American Society of Hematology Thrombophilia Guidelines Could Provoke Surge in Laboratory Testing.

Journal: Clinical chemistry

Published: September 25, 2024

Trends in Specialty Training and National Institutes of Health Funding Among Surgeon-Scientists.

Trends in Specialty Training and National Institutes of Health Funding Among Surgeon-Scientists.

Journal: Annals of surgery open : perspectives of surgical history, education, and clinical approaches

Published: September 25, 2024

Extracellular histones: a unifying mechanism driving platelet-dependent extracellular vesicle release and thrombus formation in COVID-19.

Extracellular histones: a unifying mechanism driving platelet-dependent extracellular vesicle release and thrombus formation in COVID-19.

Journal: Journal of thrombosis and haemostasis : JTH

Published: November 21, 2023

Showing 1-12 of 113

Last Updated: 09/26/2026